Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: May 20, 2026
An intra-patient contemporaneous comparison of 18F-piflufolastat and 18F-flotufolastat urinary radioactivity and pelvic region detection rates in men with low PSA biochemical recurrence of prostate cancer after radical prostatectomy.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 23, 2025
Nonoperative Management of Mismatch Repair-Deficient Tumors.
Journal: The New England journal of medicine
Published: September 24, 2025
Packing the Punch: Current and Emerging Treatment Strategies in Metastatic Castration-Sensitive Prostate Cancer.
Journal: Current urology reports
Published: April 25, 2025
Temporal Trends and Socioeconomic Determinants of Cytoreductive Nephrectomy Utilization for Metastatic Renal Cell Carcinoma in the USA.
Journal: European urology focus
Published: February 18, 2025
Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial.
Journal: European urology oncology
Published: February 04, 2025
18F-Flotufolastat Positron Emission Tomography in African American Patients With Suspected Prostate Cancer Recurrence: Findings From the Phase 3 SPOTLIGHT Study.
Journal: Advances in radiation oncology
Published: February 15, 2024
Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review.
Journal: European urology oncology
Published: January 22, 2024
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles.
Journal: The Journal of clinical investigation
Published: December 27, 2023
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma.
Journal: The Journal of clinical investigation
Published: September 27, 2023
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy.
Journal: European urology oncology
Published: September 03, 2023
Last Updated: 09/26/2026